{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:10:24Z","timestamp":1756278624648,"version":"3.44.0"},"reference-count":7,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,1,13]]},"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Polyarteritis nodosa (PAN) is a medium vessel vasculitis with necrotising vascular changes along with multisystemic involvement. Due to variable initial presentations, diagnosis of systemic PAN in children requires a comprehensive work up. In addition, systemic PAN needs an aggressive therapy. Mycophenolate mofetil is an emerging newer alternative for the treatment of PAN. We report a case of childhood systemic PAN who initially presented with subtle signs like reduced sensation over lateral foot, non-deforming arthritis and multiform rashes. After comprehensive aetiological work up, nerve biopsy and supporting evidence clinched the diagnosis. Vasculitis in children presenting with benign subtle signs is sometimes a diagnostic challenge to clinicians. Our case highlights the importance of lateral thinking while dealing with non-specific multisystemic signs. Evidence of successful treatment of PAN with mycophenolate mofetil is gradually being built up. It is also described to result lower relapse and increased treatment free survival rate.<\/jats:p>","DOI":"10.1136\/bcr-2021-248477","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T11:34:03Z","timestamp":1644406443000},"page":"e248477","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Mycophenolate mofetil in the treatment of childhood systemic polyarteritis nodosa"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4838-5037","authenticated-orcid":false,"given":"Dharmagat","family":"Bhattarai","sequence":"first","affiliation":[{"name":"Pediatrics, Om Hospital and Research Centre, Kathmandu, Bagmati, Nepal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-4267","authenticated-orcid":false,"given":"Aaqib Zaffar","family":"Banday","sequence":"additional","affiliation":[{"name":"Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita","family":"Nori","sequence":"additional","affiliation":[{"name":"Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anju","family":"Gupta","sequence":"additional","affiliation":[{"name":"Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"2025082623462637000_15.2.e248477.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.116657"},{"key":"2025082623462637000_15.2.e248477.2","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/rheumatology\/key322","article-title":"European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative","volume":"58","author":"de Graeff","year":"2019","journal-title":"Rheumatology"},{"key":"2025082623462637000_15.2.e248477.3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/art.41730","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in childhood polyarteritis nodosa: an open-label, randomized, Bayesian Noninferiority trial","volume":"73","author":"Brogan","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025082623462637000_15.2.e248477.4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009742.2017.1412497","article-title":"Epidemiology of primary systemic vasculitis in children: a population-based study from southern Sweden","volume":"47","author":"Mossberg","year":"2018","journal-title":"Scand J Rheumatol"},{"key":"2025082623462637000_15.2.e248477.5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.semarthrit.2021.04.009","article-title":"Systematic review of childhood-onset polyarteritis nodosa and DADA2","volume":"51","author":"Kasap Cuceoglu","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025082623462637000_15.2.e248477.6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/1756-185X.13120","article-title":"Comparing polyarteritis nodosa in children and adults: a single center study","volume":"20","author":"Erden","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2025082623462637000_15.2.e248477.7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.autrev.2018.08.001","article-title":"Childhood- versus adult-onset polyarteritis nodosa results from the French vasculitis Study Group registry","volume":"17","author":"Iudici","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-248477","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:46:33Z","timestamp":1756277193000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-248477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":7,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,9]]},"published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1136\/bcr-2021-248477"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-248477","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}